Page last updated: 2024-11-07

2-acetylaminofluorene and Cardiovascular Diseases

2-acetylaminofluorene has been researched along with Cardiovascular Diseases in 1 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindholm, L1
Bryngelsson, T1
Pero, R1

Other Studies

1 other study available for 2-acetylaminofluorene and Cardiovascular Diseases

ArticleYear
Hypertension, age, and smoking related to genotoxic sensitivity in human lymphocytes: a population study.
    Environmental research, 1986, Volume: 40, Issue:1

    Topics: 2-Acetylaminofluorene; Aged; Aging; Blood Pressure; Cardiovascular Diseases; DNA; Humans; Hypertensi

1986